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Abstract
ABCA7, a close relative of ABCA1 which facilitates cholesterol efflux to lipid-poor apoproteins, has been implicated in
macrophage lipid efflux and clearance of apoptotic cells in in vitro studies. In the current study, we investigated the in vivo
effects of macrophage ABCA7 deficiency on lipid metabolism and atherosclerosis. Chimeras with dysfunctional ABCA7 in
macrophages and other blood cells were generated by transplantation of bone marrow from ABCA7 knockout (KO) mice
into irradiated low-density lipoprotein receptor (LDLr) KO mice. Unexpectedly, macrophage ABCA7 deficiency did not
significantly affect atherosclerosis susceptibility of LDLr KO mice after 10 weeks Western-type diet feeding. However, ABCA7
deficiency was associated with 2-fold (p,0.05) higher macrophage ABCA1 mRNA expression levels. Combined disruption of
ABCA1 and ABCA7 in bone-marrow-derived cells increased atherosclerotic lesion development (1.5-fold (p.0.05) as
compared to wild type transplanted mice. However, single deletion of ABCA1 had a similar effect (1.8-fold, p,0.05).
Macrophage foam cell accumulation in the peritoneal cavity was reduced in ABCA1/ABCA7 dKO transplanted animals as
compared to single ABCA1 KO transplanted mice, which was associated with increased ABCG1 expression. Interestingly,
spleens of ABCA1/ABCA7 double KO transplanted mice were significantly larger as compared to the other 3 groups and
showed massive macrophage lipid accumulation, a reduction in CD3+ T-cells, and increased expression of key regulators of
erythropoiesis. In conclusion, deletion of ABCA7 in bone marrow-derived cells does not affect atherogenesis in the arterial
wall neither in the absence or presence of ABCA1. Interestingly, combined deletion of bone marrow ABCA1 and ABCA7
causes severe splenomegaly associated with cellular lipid accumulation, a reduction in splenic CD3+ T cells, and induced
markers of erythropoeisis. Our data indicate that ABCA7 may play a role in T cell proliferation and erythropoeisis in spleen.
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Introduction
Reverse cholesterol transport (RCT), defined as the transport of
accumulated cholesterol from peripheral tissues back to the liver
for biliary excretion, plays an important protective role in
atherogenesis [1,2]. In this process, cholesterol efflux represents
a crucial mechanism to maintain cellular lipid homeostasis in
macrophages and to prevent pathological foam cell formation, a
hallmark of atherosclerosis. A key regulator of macrophage
cholesterol and phospholipid efflux is Adenosine-triphosphate-
Binding Cassette (ABC) transporter ABCA1. ABCA1 promotes
the first step in RCT, namely the efflux of cholesterol and
phospholipids to lipid-poor apolipoprotein such as apolipoprotein
(apo) A-I, thereby initiating the generation of high-density
lipoprotein (HDL) [3,4,5]. Mutations in the ABCA1 gene are
the underlying cause of Tangier disease in humans, characterized
by intracellular cholesterol accummulation and severe HDL-
deficiency associated with cardiovascular disease [6,7,8,9]. In
addition to ABCA1, macrophage ABCG1 also plays a significant
role in macrophage lipid homeostasis by inducing cellular
cholesterol efflux to mature HDL [10,11].
Several other ABC transporters are expressed in monocyte-
derived macrophages and have been suggested to be involved in
lipid transport processes, RCT, and atherosclerosis [12,13].
Amongst them is ABCA7, which is a very close relative of ABCA1
(54% homology; both,220 kDa) and has been anticipated to play
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a role in cellular cholesterol homeostasis [14]. ABCA7, a full-size
ABC transporter, is detected in both the plasma membrane and in
intracellular compartments and is expressed predominantly in
myelo-lymphatic tissues with highest expression in peripheral
leukocytes, thymus, spleen, and bone marrow [14,15].
Interestingly, computer-based analysis of the ABCA7 genomic
region upstream of the transcriptional start site revealed multiple
potential binding sites for transcription factors with roles in
hematopoiesis, in particular in the development and activation of
cells of the myeloid lineage [16]. While not yet confirmed
experimentally, this finding is consistent with the preferential
distribution of ABCA7 in hematopoietic tissues.
Expression of ABCA7 is induced during in vitro differentiation of
human monocytes into macrophages and it is reported to be a
sterol-sensitive gene [14,17]. Both the ABCA7 mRNA and protein
expression in human macrophages were upregulated by acetylated
low-density lipoprotein (LDL) loading and downregulated under
HDL deloading conditions [14]. In macrophages, ABCA7 thus
exhibits a similar regulatory response to cholesterol influx and
efflux as ABCA1 and ABCG1 [18,19]. In contrast, Iwamoto et al.
[17] reported that in mouse embryonic fibroblasts, ABCA7 is
upregulated by cellular cholesterol depletion and downregulated
upon cholesterol loading through the sterol regulatory element
binding protein (SREBP) 2 pathway.
Human ABCA7 mediates the apolipoprotein-dependent gener-
ation of HDL by releasing both cellular cholesterol and
phospholipids in transfected HEK293 cells [20,21]. Likely,
another study reported that ABCA7 functions as a lipid
transporter with efflux specificity for phospholipids over choles-
terol in HEK293 cells overexpressing ABCA7 [22]. However,
genetic knockdown of ABCA7 by two different approaches in
mouse peritoneal macrophages did not affect phospholipid or
cholesterol efflux activity to apoA-I [23]. Accordingly, macro-
phages isolated from ABCA7 null mice displayed a normal
apolipoprotein-mediated capacity to efflux both phosphatidylcho-
line and cholesterol in vitro [24]. All together, ABCA7 has been
implicated in several physiologically important pathways, never-
theless its role in macrophage foam cell formation in vivo and
atherosclerosis remains unknown. Therefore, the goal of the
present study was to gain insight into the role of ABCA7 in
atherosclerotic lesion development. Since ABCA7 deficiency in
macrophages led to a significant up-regulation of ABCA1, we
compared the effects of combined macrophage ABCA1 and
ABCA7 deletion with single macrophage deficiencies of these
transporters on lipid metabolism and atherosclerosis in vivo by
means of the bone marrow transplantation (BMT) strategy.
Materials and Methods
Animals
ABCA7 knockout (ABCA7 KO) mice were generated and
kindly provided by Dr. M.W. Freeman (Massachusetts General
Hospital, Boston, USA). ABCA1 knockout (ABCA1 KO) and
ABCA7 KO mice were backcrossed onto a pure C57BL/6
background for .12 and .7 generations, respectively, and cross-
bred to generate ABCA1/A7 double knockout (dKO) mice at the
Centre d’Immunologie de Marseille Luminy. Homozygous LDL
receptor knockout (LDLr KO) mice were obtained from The
Jackson Laboratory (Bar Harbor, Me) as mating pairs and bred at
the Gorlaeus Laboratory (Leiden, The Netherlands). Mice were
housed in sterilized filter-top cages in a temperature-controlled
room with a 12-h light/dark cycle and food and water were
provided ad libitum. Mice were maintained on sterilized regular
chow, containing 4.3% (w/w) fat and no cholesterol (RM3, Special
Diet Services, Witham, UK) or fed Western-type diet (WTD) to
induce atherosclerosis, containing 15% (w/w) fat and 0.25% (w/w)
cholesterol (Diet W, Abdiets, Woerden, The Netherlands).
Drinking water was supplied with antibiotics (83 mg/L ciproflox-
acin and 67 mg/L polymyxin B sulfate) and 6.5 g/L sucrose.
Animal experiments were performed at the Gorlaeus Laboratories
of the Leiden/Amsterdam Center for Drug Research in
accordance with the National Laws (ID 04081.1). All experimental
protocols were approved by the Ethics Committee for Animal
Experiments of Leiden University and carried out in compliance
with the Dutch government guidelines.
Bone marrow transplantation (BMT)
To induce bone marrow aplasia, LDLr KO recipient mice of
10–12 weeks old were exposed to a single dose of 9 Gy (0.19 Gy/
min, 200 kV, 4 mA) total body irradiation using an Andrex Smart
225 Ro¨ntgen source (YXLON International, Hamburg, Germany)
with a 6-mm aluminum filter 1 day before the transplantation
(n= 14–15 per group). Bone marrow was isolated by flushing the
femurs and tibias from the donor ABCA7 KO and C57BL/6 wild
type (WT) (first BMT) or ABCA1 KO, ABCA7 KO, dKO and
WT (second BMT) mice with phosphate-buffered saline (PBS).
Single-cell suspensions were obtained by passing the cells through
a 70 mm cell strainer (Falcon, The Netherlands). Irradiated
recipients received 56106 bone marrow cells by intravenous
injection into the tail vein. After a BMT recovery period of 8
weeks mice were fed WTD for 10 weeks, after which animals were
sacrificed. Body mass was recorded weekly throughout the study.
At the end of the study successful reconstitution of recipient mice
with donor bone marrow was confirmed by analysis of ABCA1
and ABCA7 transcripts in genomic DNA from bone marrow of
the transplanted mice.
Assessment of successful bone marrow reconstitution
The hematologic chimerism of the LDLr KO mice was
determined using genomic DNA from bone marrow by polymer-
ase chain reaction (PCR) at 18 weeks after transplant. The forward
and reverse primers 59-TGGGAACTCCTGCTAAAAT-39 and 59-
CCATGTGGTGTGTAGACA-39 for mouse endogenous ABCA1
gene; 59-TTTCTCATAGGGTTGGTCA-39 and 59-TGCAATC-
CATCTTGTTCAAT-39 for mouse targeted ABCA1 gene; 59-
CTGCTCAGCTACAGCCTGTGG-39, 59-CAT GATGACCA-
CACGAGAGCC-39 and, 59-CGGATCCGCTGTAAGTCTG-
CA-39 for mouse endogenous and targeted ABCA7 gene were
used.
Serum lipid and lipoprotein analyses
After an overnight fast, <100 mL of blood was drawn from each
mouse by tail bleeding. The concentrations of total cholesterol in
serum were determined using enzymatic colorimetric assays as
described previously [25]. The concentrations of phospholipids
and triglycerides in serum were determined using enzymatic
colorimetric assays (Spinreact S.A., Girona, Spain and Roche
Diagnostics, Mannheim, Germany, respectively). Precipath I
(Roche Diagnostics, Mannheim, Germany) was used as an internal
standard. Absorbance was read at 490 nm. The distribution of
lipids over the different lipoproteins in serum was determined by
fractionation of 30 ml serum of each mouse using a Superose 6
column (3.26300 mm, Smart-system, Pharmacia, Uppsala, Swe-
den). Cholesterol contents in the effluent were determined as
above. After 10 weeks WTD feeding, total blood cells were
quantified using an automated Sysmex XT-2000iV analyzer
(Goffin Meyvis, Etten-Leur, The Netherlands).
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Lipid extraction of peritoneal leukocytes and spleen
Liver lipids were extracted with isopropyl alcohol–hexane as
described [26], dried with nitrogen, reconstituted with isopropyl
alcohol–0.5% sodium cholate, and sonicated for 10 min (50 Hz)
on ice, prior to lipid measurements.
Analysis of peritoneal leukocytes
After 10 weeks WTD feeding, the peritoneal cavity of 6–7 mice
per group were lavaged with 10 ml cold PBS to collect non-
thioglycollate stimulated peritoneal leukocytes for quantification of
macrophage foam cells using an automated Sysmex XT-2000iV
analyzer (Goffin Meyvis, Etten-Leur, The Netherlands). Corre-
sponding samples were cytospun using the Thermo Shandon
Cytospin 4 (5 min at 500 rpm) for manual confirmation and
stained with Oil red O for detection of lipid accumulation.
Flow cytometry analysis
After 10 wks of WTD feeding, the mice (not thioglycollate
stimulated) were sacrificed and blood, spleen, liver, lymph nodes,
thymus, bone marrow and peritoneal macrophages were isolated
(5 per group). Single cell suspensions were obtained by mashing
the cells trough a 70 mm cell strainer (Falcon, The Netherlands).
Red blood cells in blood, bone marrow and spleen samples
were lysed using 0.83% NH4Cl in 0.01 M Tris/HCl, pH 7.2.
Mononuclear cells from the liver were isolated using Lymph-
olyte (Cedarlane Laboratories, Ontario, Canada). Subsequently,
300.000 cells were stained with the appropriate antibodies
(eBioscience, Halle-Zoersel, Belgium) to determine cell subsets of
interest: T cells (CD3+ (total), CD4+ (T helper), CD8+ (cytotoxic),
CD4+CD25high (regulatory), CCR7 (homing of cells to lymphoid
organs), TCRbNK1.1 (natural killer), monocytes (CD14+) and B
cells (CD19+), macrophages (F4/80+, CD11b+, CD23+F4/80+
(M1 class), CD232F4/80+CD86+ (M2 class)), dendritic cells
(CD11c+, MHCII+, CD86+). FACS analysis was performed on
the FACSCalibur (Becton Dickinson, Mountain View, CA, USA).
Data were analyzed using Cell Quest software.
Macrophage cholesterol efflux studies
After 10 weeks WTD feeding, 5–7 mice per group were injected
with 3% Brewer’s thioglycollate medium to induce the infiltration
of macrophages into the peritoneal cavity. At 5 days after
injection, the peritoneal cavity of the mice was lavaged with
10 mL cold PBS to collect thioglycollate-elicited peritoneal
leukocytes. Subsequently, thioglycollate-elicited peritoneal macro-
phages were incubated with 0.5 mCi/mL 3H-cholesterol in
DMEM/0.2% BSA (fatty acid free) for 24 hours at 37uC. To
determine cholesterol loading, cells were washed 3 times with
washing buffer (50 mmol/L Tris containing 0.9% NaCl, 1 mmol/
L EDTA, and 5 mmol/L CaCl2, pH 7.4), lysed in 0.1 mol/L
NaOH, and the radioactivity was determined by liquid scintilla-
tion counting. Cholesterol efflux was studied by incubation of the
cells with DMEM/0.2% BSA alone or supplemented with either
10 mg/mL apoA-I (Calbiochem, San Diego, USA) or 50 mg/mL
human HDL (density 1.063 to 1.21 g/mL, isolated according to
Redgrave et al.) as lipid acceptors. Radioactivity in the medium
and the cells was determined by scintillation counting after
24 hours of incubation. Cholesterol efflux was calculated as the
amount of radioactivity in the medium compared to the total
amount of radioactivity measured in medium plus cells.
Histological and tissue lipid analysis
To analyze lipid accumulation in the different tissues, mice were
sacrificed after 10 weeks (18 weeks after BMT) on WTD. After in
situ perfusion, organs were excised and stored in 3.7% neutral-
buffered formalin (Formal-fixx; Shandon Scientific Ltd, UK).
Subsequently, cryosections of formalin-fixed lung, liver, mesenteric
lymph nodes, spleen, and the aortic root in the heart were
prepared from all groups of mice and stained for lipid
accumulation using Oil red O. Hematoxylin (Sigma Diagnostics,
St. Louis, MO, USA) was used to stain the nuclei in the different
organs. Atherosclerotic mean lesion area (in mm2) was quantified in
the aortic root from ten Oil red O-stained sections for each
animal, starting at the appearance of the tricuspid valves.
Corresponding sections of atherosclerotic lesions and the spleen
were stained immunohistochemically with antibodies against
macrophage F4/80 specific antigen (polyclonal rat IgG2b,
Research Diagnostics Inc, NJ) or against lymphocyte CD3 antigen
(SP7)(NeoMarkers, Fremont, CA). Apoptotic cells in atheroscle-
rotic lesions and spleen cells were identified by terminal
deoxynucleotidyl transferase-mediated dUTP nick end-labeling
(TUNEL) staining using the In Situ Cell Death Detection Kit
(Roche Diagnostics, Mannheim, Germany). TUNEL-positive
nuclei were visualized with Nova Red (Vector Laboratories,
Burlingame, CA, USA), and sections were counter stained with
0.3% methylgreen. The level of apoptosis was expressed as the
percentage of TUNEL-positive cells and as amount of TUNEL-
positive cells per mm2 lesion area. Sections pre-treated with DNase
(2 U per section) enabled labeling of all cells and served as positive
control. A polyclonal rabbit anti Ki67 antibody (Abcam, Cam-
bridge, UK) was used to determine spleen cell proliferation rate. A
rat TER 119 antibody (Santa Cruz Biotechnology Inc., Germany)
was used as the primary antibody to immunohistochemically stain
spleen erythroid lineage of mouse origin [27]. All quantifications
were performed blinded by using the Leica image analysis system,
consisting of a Leica DMRE microscope coupled to a video
camera and Leica Qwin Imaging software (Leica Ltd., Cambridge,
UK).
Electron microscopy
Spleens were fixed in 3.7% neutral-buffered formalin (Formal-
fixx; Shandon Scientific Ltd, UK), post-fixed in 1% OsO4 in the
same buffer for 1 hour at 4uC, dehydrated in a graded ethanol
series and embedded in Epon. Ultrathin sections were post-stained
with uranyl acetate and lead citrate and viewed with a CM10
electron microscope at 80 kV (Philips, Eindhoven, The Nether-
lands).
Gene mRNA and protein expression analysis
Guanidium thiocyanate-phenol was used to extract total RNA
from peritoneal macrophages and spleens. cDNA was generated
using RevertAid M-MuLV reverse transcriptase (Fermentas,
Burlington, Canada) according to manufacturer’s protocol.
Quantitative gene expression analysis was performed using the
SYBR-Green method on a 7500 fast Real-time PCR machine
(Applied Biosystems, Foster City, CA). PCR primers (Table 1)
were designed using Primer Express Software according to the
manufacturer’s default settings. Hypoxanthine Guanine Phos-
phoribosyl Transferase (HPRT), b-actin, and acidic ribosomal
phosphoprotein PO (36B4) were used as the standard housekeep-
ing genes. Relative gene expression was calculated by subtracting
the threshold cycle number (Ct) of the target gene from the
average Ct of housekeeping genes and raising two to the power of
this difference, in order to exclude the possibility that changes in
the relative expression were caused by variations in expression of a
single housekeeping gene.
Immunoblotting on protein from peritoneal macrophages was
performed as described previously [28]. In short, after running
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equal amounts of total cell protein (60 mg) on a 7.5% SDS-PAGE
gel, ABCA1 was detected using murine monoclonal ABCA1
primary antibody (AC-10; a kind gift from Dr. M. Hayden,
Vancouver, Canada) and ABCG1 was detected using polyclonal
rabbit anti-mouse ABCG1 primary antibody (Novus Biologicals,
Cambridge, UK) and a peroxidase-conjugated goat-anti-mouse
IgG secondary antibody (Jackson ImmunoResearch, Suffolk, UK).
Murine monoclonal b-actin antibody (Santa Cruz Biotechnology,
Heidelberg, Germany) was used as a loading control. Finally,
immunolabeling was detected by enhanced chemiluminescence
(Thermo Scientific, Rockford, USA).
Data analyses
Data are expressed as mean 6 S.E.M. To compare differences
among groups One-way ANOVA with Tukey’s post-test was
performed using GraphPad Prism version 4.00 for Windows
(GraphPad Software, San Diego, CA, USA, www.graphpad.com).
A P value,0.05 was considered statistically significant.
Results
Effect of macrophage ABCA7 deficiency on plasma lipid
levels, atherogenesis and macrophage ABCA1 expression
ABCA7 was selectively disrupted in hematopoietic cells, thus
including macrophages, by transplantation of bone marrow from
ABCA7 KO mice into LDLr KO mice, which represent a
recognized model for the development of atherosclerosis. After a
recovery period of 8 weeks on regular murine chow diet, the
transplanted mice were challenged with a high cholesterol, high fat
WTD containing 0.25% cholesterol and 15% cacao butter. No
significant effect of macrophage ABCA7 deficiency was observed
on serum free cholesterol (FC) levels, total cholesterol (TC),
triglyceride (TG) or phospholipids (PL) (Fig. 1A). The effect on
atherosclerosis susceptibility was analyzed in the aortic root of the
transplanted LDLr KO mice after 10 weeks WTD feeding.
Deletion of ABCA7 in macrophages did not significantly modify
the lesion size (p.0.05) (Fig. 1B). Interestingly, the mRNA
expression of the key lipid transporter ABCA1 was up-regulated 2-
fold in ABCA7-deficient peritoneal macrophages (p = 0.028)
(Fig. 1C). We have previously shown that macrophage ABCA1
overexpression inhibits atherosclerotic lesion progression in LDLr
KO mice [29]. Thus, to gain further insight into the impact of
ABCA7 expression on lipid metabolism and atherogenesis, the
effect of combined macrophage ABCA1 and ABCA7 disruption
was evaluated by means of BMT.
Effect of combined macrophage ABCA1 and ABCA7
disruption on plasma lipids levels in LDLr KO mice
Bone marrow from WT, ABCA1 KO, ABCA7 KO, and dKO
mice was transplanted into LDLr KO mice. From 8 weeks after
bone marrow transplantation, the transplanted mice were
challenged with the WTD to induce atherosclerotic lesion
development. Similar as in the first BMT experiment, ABCA7
deletion in bone marrow-derived cells did not affect serum TC,
TG or PL levels (Fig. 2A). However, in agreement with previous
studies [30], deletion of ABCA1 in bone marrow cells resulted in
significantly lower serum lipid levels compared to WT transplant-
ed mice when fed WTD (TC: 0.5-fold; p,0.001, PL: 0.7-fold,
p,0.001, TG: 0.5-fold, p,0.05). A similar decrease in serum
lipids levels was found in LDLr KO mice transplanted with bone
marrow lacking both ABCA1 and ABCA7 (TC: 0.4-fold;
p,0.001, PL: 0.4-fold, p,0.001, TG: 0.2-fold; p,0.01).
Fractionation of serum lipoproteins showed that ABCA1 and
dKO transplanted mice exhibited lower VLDL and LDL
cholesterol levels (Fig. 2B and Table 2). VLDL production
analysis showed a significantly lower VLDL production rate in
mice lacking ABCA1 in bone-marrow derived cells (1.8-fold;
p,0.05) compared to control, which is in line with the observed
reduction in plasma TG levels in LDLr KO mice transplanted
with ABCA1 or ABCA1/A7 deficient bone marrow cells. No
significant effects of macrophage ABCA1, ABCA7 or combined
ABCA1/ABCA7 deficiency were observed on HDL cholesterol
levels.
Effect of macrophage ABCA1 and ABCA7 disruption on
foam cell formation and atherosclerotic lesion formation
As in vivo foam cell formation within the peritoneal cavity is
indicative for the susceptibility to atherosclerotic lesion develop-
Table 1. Primers used for quantitative real-time RT-PCR analysis.
Gene GeneBank Accession Forward primer Reverse Primer
b-actin X03672 AACCGTGAAAAGATGACCCAGAT CACAGCCTGGATGGCTACGTA
36B4 X15267 GGACCCGAGAAGACCTCCTT GCACATCACTCAGAATTTCAATGG
HPRT J00423 TTGCTCGAGATGTCATGAAGGA AGCAGGTCAGCAAAGAACTTATAG
ABCA1 NM_013454 GGTTTGGAGATGGTTATACAATAGTTGT TTCCCGGAAACGCAAGTC
ABCG1 NM_009593 AGGTCTCAGCCTTCTAAAGTTCCTC TCTCTCGAAGTGAATGAAATTTATCG
CD3 NM_007648.3 CTGTCTAGAGGGCACGTCAA GATGCGGTGGAACACTTTCT
CD4 NM_013488 GAGCTCTTGTTGGTTGGGAA CGAACATCTGTGAAGGCAAA
CD68 NM_009853 CCTCCACCCTCGCCTAGTC TTGGGTATAGGATTCGGATTTGA
CD19 NM_009844 CTGGGACTATCCATCCACCA TGTCTCCGAGGAAACCTGAC
EPOr BC_046282 CAACAGCGGACACATCGAGTT TAGCGAGGAGAACCGGACG
GATA-1 NM_008089 TGGAATCCAGACGAGGAACC CTCCAGCCAGATTCGACCC
FOG-1 NM_009569 TCCCCTGAGAGAGAAGAACCG GCAGCATCCTTAGCCAGCA
TAL-1 NM_011527 CTAGGCAGTGGGTTCTTTGGG CCTCTTCACCCGGTTGTTGTT
36B4 = acidic ribosomal phosphoprotein PO; HPRT = hypoxanthine guanine phosphoribosyl transferase; ABC =ATP-binding cassette transporter; SR-BI = scavenger
receptor class B1; EPOr = erythropoietin receptor; GATA-1 = globin transcription factor 1; FOG-1 = friend of GATA-1; Tal-1 = basic helix-loop-helix factor.
doi:10.1371/journal.pone.0030984.t001
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Figure 2. Plasma lipid levels and cholesterol lipoprotein distribution profile after 10 weeks WTD feeding of LDLr KO mice
reconstituted with WT, ABCA1 KO, ABCA7 KO and dKO bone marrow. Blood samples were drawn after an overnight fast. (A) The
concentrations of cholesterol, phospholipids and triglycerides in serum were determined using enzymatic colorimetric assays. (B) The distribution of
cholesterol over the different lipoproteins was determined by fractionation of serum from individual mice using a Superose 6 column. Fractions 2 to 5
represent VLDL; fraction 6 to 14, LDL; and fractions 15 to 20, HDL, respectively. Values represent the mean6SEM of $6 mice per group. Statistically
significant difference *p,0.05, **p,0.01, and *** p,0.001.
doi:10.1371/journal.pone.0030984.g002
Figure 1. Effects of macrophage ABCA7 deficiency on plasma lipid levels, atherosclerosis and ABCA1 expression in peritoneal
macrophages from LDLr KO mice reconstituted with WT and ABCA7 KO bone marrow. (A) Blood samples were drawn after an overnight
fast. The concentrations of cholesterol, phospholipids and triglycerides in serum were determined using enzymatic colorimetric assays. (B) The mean
lesion area (mm2) was calculated from Oil red O-stained cross-sections of the aortic root at the level of the tricuspid valves. (C) Guanidium
thiocyanate-phenol was used to extract total RNA from cells and mRNA expression was determined by real-time RT-PCR. Hypoxanthine Guanine
Phosphoribosyl Transferase (HPRT), b-actin, and acidic ribosomal phosphoprotein PO (36B4) were used as the standard housekeeping genes. Relative
gene expression was calculated by subtracting the threshold cycle number (Ct) of the target gene from the average Ct of housekeeping genes and
raising two to the power of this difference. Values represent the mean 6 SEM of $6 mice per group. Statistically significant difference *p,0.05.
doi:10.1371/journal.pone.0030984.g001
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ment [31,32], the effect of deletion of macrophage ABCA1 and/or
ABCA7 on the presence of foam cells in the peritoneal cavity was
investigated. Disruption of macrophage ABCA7 did not induce
foam cell accumulation in the peritoneal cavity (0.2060.03%
[n= 5] compared to 0.2060.07% [n=7] for control animals;
p.0.05) (Fig. 3A). As expected, a 30-fold increase in foam cell
formation was detected in ABCA1 KO transplanted mice as
compared to the controls (6.2560.65% [n= 8] vs 0.2060.07%
[n= 7]; p,0.001). DKO transplanted animals exhibited also a
highly significant increase in the amount of foam cells compared to
control animals (2.8860.19% [n=5] compared to WT
0.2060.07% [n= 7]; p,0.01), which, however, was less severe
than in single ABCA1 KO transplanted mice (p,0.001) (Fig. 3A).
The increase in foam cells in ABCA1 KO and dKO transplanted
mice was also indicated by microscopic visualization using Oil red
O-stained cytospins (Fig. 3B) and confirmed by extracting tissue
lipids with organic solvents (Fig. 3C). Lipid extraction analyses
from cells showed an increase in TC levels in ABCA1 KO and
dKO transplanted mice compared to WT (4-fold, p,0.01 and 2.6-
fold, p.0.05, respectively) transplanted mice (Fig. 3C).
To investigate the effect of deletion of macrophage ABCA1
and/or ABCA7 on atherosclerotic lesion development, lesion sizes
in Oil red-O stained sections of the aortic root were quantified
after 10 weeks WTD feeding. Again, single deletion of macro-
phage ABCA7 did not affect atherosclerotic lesion development as
compared to control animals (2396276103 mm2 [n=10] com-
pared to 2346286103 mm2 [n= 13]; p.0.05) (Fig. 4A and B).
Furthermore, in agreement with our previous study [30], single
disruption of macrophage ABCA1 resulted in a 1.8-fold increase in
atherosclerotic lesion size as compared to lesions in WT
transplanted animals (4126676103 mm2 [n= 11] compared to
2346286103 mm2 [n= 13]; p,0.05)(Fig. 4). Combined deletion
of macrophage ABCA1 and ABCA7 led to a 1.3-fold increase in
atherosclerotic lesion, which was however not statistically signi-
ficant different from the WT transplanted mice (3486526
103 mm2 [n= 7] compared to 2346286103 mm2 [n= 13]). The
percentage of TUNEL-positive nuclei did not differ between
experimental groups (WT: 3.561.3%, ABCA1 KO: 8.362.5%,
ABCA7 KO: 6.862.6%, dKO: 2.360.4); however, both ABCA1
KO and dKO transplanted mice showed a significant increase in
necrotic core compared with control animals (3368 and 3369%
of total lesion compared with 562% of total lesion, p,0.05 and
p,0.01, respectively) (Fig. 4C). Lesions were mainly occupied by
macrophages as shown by F4/80 staining (Figure S1).
Interestingly, dKO transplanted mice, thus, showed a less severe
increase in both foam cells and atherosclerotic lesion size
compared with ABCA1 KO transplanted mice, indicating that
ABCA7 deletion attenuates the effect of ABCA1 deletion on foam
cell formation and atherosclerosis. To determine what might be
causitive for the attenuated macrophage foam cell formation in vivo
upon combined deletion of ABCA1 and ABCA7, the expression of
ABCG1 was determined in the peritoneal cells as well as ABCA1
and ABCA7. Absence of ABCA1 in macrophages did not affect
the mRNA expression levels of ABCG1 (Fig. 3D) nor ABCA7
(data not shown). Similarly to the findings from the first BMT
study (Fig. 1C), macrophages of ABCA7 KO transplanted mice
showed a 5-fold significant increase in ABCA1 mRNA expression
compared to control animals (p,0.05). In agreement, western-blot
analyses showed that also ABCA1 protein expression levels were
upregulated (1.7-fold, p,0.05) in macrophages deficient in
ABCA7 (Fig. 3E). As expected, deletion of macrophage ABCA1
resulted in a complete absence of ABCA1 mRNA and thus
abrogated the upregulation of ABCA1 upon deletion and ABCA7.
Importantly, also the mRNA expression levels of ABCG1 were
increased in ABCA7 KO and dKO transplanted mice compared
to control and ABCA1 KO transplanted mice, which, however,
only reached significance compared to ABCA1 KO transplanted
mice (p,0.05 and p,0.01, respectively). However, protein
expression levels of ABCG1 were only induced in macrophages
with combined deletion of ABCA1 and ABCA7 (2.5-fold, p,0.05)
(Fig. 3E). These data suggest that the decreased foam cell
formation in dKO transplanted animals as compared to single
ABCA1 KO transplanted mice might be the consequence of
enhanced efflux to HDL by ABCG1.
Therefore, next the effect of ABCA1 and ABCA7 expression on
the efflux of cholesterol from peritoneal macrophages to apoA-I
and HDL was determined in vitro. The percentage of cholesterol
effluxed from WT cells and from cells lacking ABCA7 to either
apoA-I or HDL did not differ, whereas deletion of ABCA1 or
combined deletion of ABCA1 and ABCA7 led to a completely
abolished efflux to apoA-I (both$95% decrease p,0.001 and
p,0.001, respectively) (Fig. 5). Importantly, the absence of both
ABCA1 and ABCA7 resulted in a moderate but significant 18%
reduction in efflux to HDL compared to control cells (33.961.6%
compared to 41.360.3%; p,0.05). The anticipated increase in
cholesterol efflux to HDL could, thus, not be confirmed in
peritoneal macrophages in culture.
Disturbed spleen morphology in combined ABCA1 and
ABCA7-deficient bone marrow transplanted mice
Both on chow and on WTD, WT, ABCA1 KO, ABCA7 KO,
and dKO transplanted mice did not differ in body weight (data not
shown). Furthermore, no differences in relative weight, lipid content
and cell composition in liver, thymus, and lymph nodes were
observed (data not shown). Interestingly, the relatively spleen weight
of dKO transplanted mice was increased 3-fold (8.4461.35 mg/g
body weight (bw) compared with 2.7060.14 mg/g bw in control
mice; p,0.001) (Fig. 6A), while spleen weights of ABCA1 KO and
ABCA7 KO transplanted mice did not differ compared to WT
transplanted mice. In addition, macroscopically white foci were
visible in spleens of dKO transplanted mice (Fig. 6A), which were
consistent with lipid accumulation, visualized by Oil red-O staining
Table 2. Serum cholesterol levels in WT, ABCA1 KO, ABCA7
KO and dKO bone marrow transplanted mice on chow and
WTD.
Mice
Time
(wks) Diet
VLDL-C
(mmol/L)
LDL-C
(mmol/L)
HDL-C
(mmol/L)
WT 8 Chow 0.5060.04 3.660.08 2.960.18
ABCA1 KO 8 Chow 0.4560.09 3.260.05* 2.960.16
ABCA7 KO 8 Chow 0.7360.10 3.960.19 2.960.19
dKO 8 Chow 0.4560.03 3.860.11 2.860.18
WT 18 WTD 7.061.7 11.261.1 1.860.26
ABCA1 KO 18 WTD 2.460.8* 6.460.9* 1.560.41
ABCA7 KO 18 WTD 4.761.4 9.461.1 1.660.40
dKO 18 WTD 1.460.3* 5.961.2* 1.560.28
Serum cholesterol levels were measured in LDLr2/2 at 8 and 18 weeks after
transplantation with bone marrow from WT, ABCA1 KO, ABCA7, or dKO mice. At
8 weeks after bone marrow transplantation, the regular chow diet was switched
to a high-cholesterol diet. Data represent the means6SEM of 12–16 mice.
Statistical significance of *p,0.05, **p,0.01, and ***p,0.001 compared with
WT transplanted mice. Abbreviations: WTD=Western-type diet; VLDL = very-
low-density lipoprotein; LDL = low-density lipoprotein; HDL =high-density
lipoprotein; C = cholesterol.
doi:10.1371/journal.pone.0030984.t002
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Figure 3. Effect of macrophage ABCA1, ABCA7, and combined ABCA1/ABCA7 deficiency on in vivo foam cell formation, and mRNA
and protein expression levels of ABCA1 and ABCG1. (A) Peritoneal leukocytes were analyzed using a hematology Sysmex XT-2000iV analyzer
and the number of macrophage foam cells were quantified as percentage of the total amount of isolated cells. Values represent the mean6SEM of
$5 mice per group. Statistically significant difference **p,0.01, and ***p,0.001 vs. WT. (B) Photomicrographs of oil-red O-stained cytospins of
peritoneal cells. Original magnification6400. (C) Lipids were extracted from peritoneal leukocytes with organic solvents. (D) Guanidium thiocyanate-
phenol was used to extract total RNA from peritoneal macrophages and mRNA expression was determined by real-time RT-PCR. Hypoxanthine
Guanine Phosphoribosyl Transferase (HPRT), b-actin, and acidic ribosomal phosphoprotein PO (36B4) were used as the standard housekeeping genes.
Relative gene expression was calculated by subtracting the threshold cycle number (Ct) of the target gene from the average Ct of housekeeping
genes and raising two to the power of this difference. WT samples were all calibrated to an arbitrary unit. (E) Western-blot analyses were performed
to quantify the protein expression levels of ABCA1 and ABCG1 in peritoneal leukocytes. Values represent the mean 6 SEM of 4–6 mice per group.
Statistically significant difference *p,0.05, **p,0.01 and ***p,0.001.
doi:10.1371/journal.pone.0030984.g003
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of cryostat sections of the spleen (Fig. 6B). In agreement, lipid
extraction analyses from the spleen showed a significant increase in
TC and PL levels in dKO transplanted mice compared to WT (TC:
5.4-fold, p,0.001; PL: 1.9-fold, p,0.001), ABCA1 KO (TC: 19.7-
fold, p,0.001; PL: 2.3-fold, p,0.001), and ABCA7 KO (TC: 9.4-
fold, p,0.001; PL: 2.4-fold, p,0.001) transplanted mice (Fig. 6C).
Electron microscopic analyses were performed to determine in
which cell type and cellular compartment the accumulation of
excessive amounts of lipid occured. Interestingly, massive cytoplas-
mic lipid accumulation was observed in the macrophages of dKO
transplanted mice, which was not observed in spleens of WT
transplanted mice (Fig. 6D).
Interestingly, the spleen of ABCA7 KO and dKO transplanted
LDLr KO mice also showed an increase in apoptotic cells
(Fig. 6B), which might be caused by the impaired phagocytic
capacity in ABCA7 KO transplanted mice.
To further define the effect of combined deletion of ABCA1 and
ABCA7 on splenic function, mRNA analyses were performed
(Fig. 7). Similar as observed for peritoneal macrophages, mRNA
expression of ABCA1 was increased in the spleen of ABCA7 KO
transplanted mice compared to controls (p,0.05). This increase
was not due to an increase in macrophages in spleens of ABCA7
KO transplanted mice, as no difference in CD68 mRNA
expression was observed between the 4 groups. As expected
mRNA expression of ABCA1 was diminished in spleens of
ABCA1 KO and dKO transplanted mice (p,0.01 and p,0.0001,
respectively). In contrast to the findings in peritoneal macrophag-
es, no difference was observed in expression of ABCG1 in the
spleen. Furthermore, deletion of ABCA1 did not affect ABCA7
mRNA expression (data not shown).
Figure 4. Atherosclerosis in the aortic root of LDLr KO mice reconstituted with WT, ABCA1 KO, ABCA7 KO and dKO bone marrow.
(A) The mean lesion area (mm2) was calculated from Oil red O-stained cross-sections of the aortic root at the level of the tricuspid valves. (B)
Representative pictures are shown. (C) The percentage of necrotic core of the total lesion was analysed using TUNEL staining. Values represent the
mean6SEM of $6 mice per group. Statistically significant difference *p,0.05.
doi:10.1371/journal.pone.0030984.g004
Figure 5. Effect of macrophage ABCA1, ABCA7, and combined
ABCA1/ABCA7 deficiency on cellular cholesterol efflux. Thio-
glycollate-elicited peritoneal macrophages were isolated from male
recipients at 18 weeks posttransplant. Cholesterol efflux from 3H-
cholesterol-labeled cells incubated with DMEM/0.2% BSA alone or
supplemented with either 10 mg/mL apoA-I or 50 mg/mL human HDL
was determined after 24 hours of incubation. Results are the mean6-
SEM of 4 mice per group. Statistically significant difference *p,0.05.
doi:10.1371/journal.pone.0030984.g005
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Cell subsets composition of the spleen was evaluated by
determing mRNA expression of CD3, CD4, CD68, and CD19
(Fig. 7). ABCA7 KO transplanted mice exhibited increased splenic
mRNA expression in T helper cells (CD4) compared to controls
(p,0.01). No differences were observed in B cells (CD19) and
macrophages (CD68) between the groups. Subsequently, the effect
of combined deletion of ABCA1 and ABCA7 on splenic cell
population was examined by FACS analysis (Fig. 8). Deletion of
ABCA1 and/or ABCA7 did not affect splenic F4/80+ macro-
phages, CD19+ B cells, and CD4+/CD25high regulatory T cells
compared to control mice. Single ABCA7 deficiency did show an
increase in CD4+ T helper cells, which, however, failed to reach
significance (2960.4% compared with 2560.5% in WT trans-
planted animals; p.0.05). This increase in CD4+ cells was in line
with the increase in CD4 mRNA expression measured by qPCR
analysis (Fig. 7). Remarkably, disruption of both ABCA1 and
ABCA7 on hematopoietic cells resulted in a decrease in the
percentage of splenic CD3+ T cells (2263% compared with
3964% in WT transplanted animals; p,0.01) (Fig. 8), which is
the result of a trend towards a reduction in T helper cells
(CD4+)(p.0.05) and a significant reduction in cytotoxic T cells
(CD8+)(p,0.001). A decrease in splenic CD3+ T cells in dKO
transplanted mice was also indicated by immunohistochemical
staining against lymphocyte CD3 antigen (Fig. 6B). WT, ABCA1
KO, and ABCA7 KO transplanted mice showed strong CD3+
staining in the centre of white pulp areas of the spleen, which
represents the periarterial lymphatic sheath (PALS). DKO
transplanted mice, however, showed a disturbed spleen morphol-
ogy, as the white and red pulp areas were difficult to distinguish
from each other and no strong CD3+ staining could be observed,
even not in the PALS. No effect was observed on lymphocyte
counts in the circulation nor in the thymus and lymph nodes (data
Figure 6. Effects of single macrophage ABCA7 and combined macrophage ABCA1 and ABCA7 deficiency on spleen. (A) Relative
spleen weights of transplanted mice to body weight (bw) and representative images are shown. (B) Cryosections of spleens from all groups of mice
were stained for lipid accumulation using Oil-red O staining (original magnification650 for first row and6400 for second row), against lymphocyte
CD3 antigen by immunohistochemistry (original magnification640) and for apoptosis using TUNEL staining (original magnification640). (C) Lipids
were extracted from spleens with organic solvents. Values represent the mean6SEM of $9 mice per group. Statistically significant difference
**p,0.01 and ***p,0.001. (D) Electron microscopic images of spleens from WT and dKO mice. Macrophages (mw) of dKO transplanted mice
exhibited massive cytoplasmic lipid accumulation (*).
doi:10.1371/journal.pone.0030984.g006
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not shown), indicating that the observed effects on T cells are
specific for spleen.
F4/80 staining showed, as expected, distinct macrophage-rich
areas constituting the red pulp of spleens of the WT, ABCA1
KO, and ABCA7 KO transplanted mice (Fig S2). However, the
morphology of the spleen of dKO transplanted mice was
disrupted, as the white and red pulp areas were difficult to
distinguish from each other. F4/80 staining of spleens of dKO
transplanted mice showed macrophages distributed throughout
the spleen and not localized in specific areas. As the percentage of
macrophages and B cells in the spleens of the dKO transplanted
mice was not changed (Fig. 8), it is likely that the increase
in spleen size was due to more (lipid-filled) macrophages, as
shown by Oil red-O staining (Fig. 6B) and electron microscopy
(Fig. 6D).
To evaluate whether the increase in spleen weight of dKO
transplanted mice was also a direct result of increased erythro-
poiesis, mRNA gene expression of different transcriptors involved
in splenic erythropoiesis was determined: ea erythropoietin
receptor (EPOr), globin transcription factor 1 (GATA-1), friend
of GATA-1 (FOG-1), and basic helix-loop-helix factor TAL-1.
The expression of EPOr, involved in the proliferation and
differentiation of the colony-forming units-erythrocyte (CFU-E)
and proerythroblasts, was significantly increased in dKO trans-
planted animals (p,0.05) (Fig. 7). In addition, dKO transplanted
mice exhibited a significant increase in GATA-1 (p,0.01) and
FOG-1 (p,0.05) genes, involved in the differentiation of
committed erythroid progenitor cells. Furthermore, disruption of
both ABCA1 and ABCA7 in hematopoietic cells resulted in a
significant increase in TAL-1 expression (p,0.05), a gene involved
in the commitment of hematopoietic cells to the erythroid lineage.
Therefore, these data indicate that the expression of key regulators
in erythropoiesis was affected in dKO transplanted animals.
Accordingly, darker staining for erythroid lineage cells (TER 119)
was observed in dKO transplanted animals, while no difference
between groups was found in the cell proliferation rate (Ki67)
(Figure S2). However, no differences in circulating red blood cells
were observed between the four groups (data not shown).
Figure 7. mRNA expression levels of genes of interest in spleens from LDLr KO mice reconstituted with WT, ABCA1 KO, ABCA7 KO
and dKO bone marrow. Guanidium thiocyanate-phenol was used to extract total RNA from organs and mRNA expression was determined by real-
time RT-PCR. Hypoxanthine Guanine Phosphoribosyl Transferase (HPRT), b-actin, and acidic ribosomal phosphoprotein PO (36B4) were used as the
standard housekeeping genes. Relative gene expression was calculated by subtracting the threshold cycle number (Ct) of the target gene from the
average Ct of housekeeping genes and raising two to the power of this difference. WT samples were all calibrated to an arbitrary unit. Values
represent the mean 6 SEM of 4–6 mice per group. Statistically significant difference *p,0.05, **p,0.01 and ***p,0.001.
doi:10.1371/journal.pone.0030984.g007
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Discussion
ABCA7 is an ABC-transporter which shows the highest protein
sequence homology with ABCA1, a key regulator of macrophage
cholesterol and phospholipid efflux to lipid-poor apoA-I and other
lipid-poor apolipoproteins [14]. Therefore, it was assumed that
ABCA7 may also function in cellular lipid or cholesterol
metabolism. In the current study, we, for the first time, show
that specific hematopoietic ABCA7 deficiency does not affect
WTD diet-induced atherosclerotic lesion development in LDLr
KO mice. Noteworthy, ABCA1 expression was upregulated 2-fold
in peritoneal macrophages lacking functional ABCA7, suggesting
that crosstalk between ABC transporter family members seems
feasible and that ABCA7, like other ABC transporters, may be
part of a complex machinery controling lipid homeostasis in
macrophages with possible (partly) overlapping functions. In
agreement, ABCA2 (Calpe-Berdiel et al. unpublished), ABCA5
[25], and ABCG1 [33] deletion independently led to compensa-
tory up-regulation of ABCA1 in these cells. In addition, our group
previously demonstrated that LDLr KO mice overexpressing
macrophage ABCA1 showed 3-fold smaller atherosclerotic lesions
[29]. Increased macrophage ABCA1 expression might thus
counteract the effect of ABCA7 deletion in foam cell formation
and atherosclerosis. To gain further insight into the impact of
ABCA7 expression on lipid metabolism and atherogenesis and to
analyze potential synergistic properties, we next evaluated the
effect of combined macrophage ABCA1 and ABCA7 disruption.
After 10 weeks of WTD feeding, macrophage ABCA7 deficiency
did not alter serum lipid or lipoprotein levels compared to control
mice, which is in line with the results found in total body ABCA7-
deficient mice reported by Kim et al. [24]. In line with previous
findings [30], disruption of macrophage ABCA1 resulted in a
decrease in lipid levels, which was similar to the reduction in lipid
levels observed in mice with combined macrophage ABCA1 and
ABCA7 deletion, indicating that this reduction is most likely
attributable to the deficiency in macrophage ABCA1. We now
show that this is, at least partly, due to decreased VLDL
production by the liver upon disruption of ABCA1 in bone
marrow-derived cells.
Despite the decreased serum lipid levels in ABCA1 KO and
ABCA1/ABCA7 dKO transplanted mice, significantly higher
amounts of foam cells were observed in the peritoneal cavity of
these animals compared to controls, while also the susceptibility to
atherosclerosis was increased. Single macrophage ABCA7 defi-
ciency did not affect foam cell formation nor atherosclerotic lesion
size. The observed increase in lesion size in dKO transplanted
mice is, thus, most likely attributable to the deficiency in
macrophage ABCA1 only. Interestingly, foam cell formation and
susceptibility to atherosclerotic lesion development in dKO
transplanted LDLr KO mice was less severe compared to single
ABCA1 KO transplanted mice, indicating that the presence of
ABCA7 augments macrophage foam cell formation and possibly
atherosclerosis in the absence of ABCA1. However, it is important
to note that dKO transplanted LDLr KO mice exhibited lower
VLDL cholesterol levels compared to ABCA1 KO transplanted
mice (0.6-fold compared with ABCA1 KO, p.0.05). Although the
difference was not significant, prolonged exposure to lower VLDL
cholesterol levels might have contributed to the observed
reduction in atherosclerotic lesion development in the dKO
transplanted mice. Macrophage apoptosis is an important feature
of atherosclerotic plaque development and occurs during all stages
of atherosclerosis with increasing frequencies as the plaque
develops. Research directed at understanding the functional
consequences of macrophage death in atherosclerosis has revealed
opposing roles for apoptosis in atherosclerotic plaque progression
[34,35]. ABCA7 has been suggested to play a role in phagocytosis
of apoptotic cells [17,36]. Therefore, in addition to the anticipated
role of ABCA7 in cholesterol homeostasis and cholesterol efflux,
ABCA7 may also affect atherosclerosis by its role in phagocytosis,
which can be pro- or antiatherogenic. However, no differences in
atherosclerotic lesion formation was observed in ABCA7 KO mice
compared to controls. Still, a positive correlation between the
amount of foam cells and the susceptibility to atherosclerosis was
found, indicating that atherogenesis, under the conditions studied,
is likely to occur independently of an anticipated role for ABCA7
in phagocytosis.
Lipid accumulation in cells, leading to the formation of foam
cells, might be due to a defect in the efflux of lipids out of the cells
to exogenous lipid acceptors. ABCA1 and ABCA7 have a high
degree of sequence homology, including the first and fourth
extracellular loops [22], suggesting that ABCA7 might be able to
bind apolipoproteins and mediate cellular lipid efflux. Wang et al.
[22] previously reported, that HEK293 cells expressing murine
ABCA7 displayed increased apoA-I binding. These findings
indicate that ABCA7 shares the functional properties of ABCA1
to transport phopholipids and cholesterol in response to
stimulation with apoA-I. However, the ability and magnitude of
the lipid transport activity of ABCA7 is disputed [20,21,22,24].
HEK293 cells expressing human ABCA7 demonstrated apoA-I-
mediated release of both phospholipids and cholesterol [20,21].
Wang et al. [22] have shown that mouse ABCA7 only promotes
apoA-I-dependent phospholipid release, but not cholesterol. In
contrary, Kim et al. [24] showed that macrophages of ABCA7-
deficient mice displayed a normal capacity to efflux both
phosphatidylcholine and cholesterol to apoA-I. The lack of an
effect on macrophage lipid efflux was postulated to be the
consequence of the absence of ABCA7 from the plasma
membrane of murine macrophages, so that no direct physical
interaction with apoA-I is possible. Ikeda et al. [15] reported that
Figure 8. Effects of single macrophage ABCA7 and combined
macrophage ABCA1 and ABCA7 deficiency on cellular spleen
composition. Spleen cell subsets measured by flow cytometry
expressed as percentage of positive cells. Values represent the mean
6 SEM of 5 mice per group. Statistically significant difference *p,0.05,
**p,0.01 and ***p,0.001.
doi:10.1371/journal.pone.0030984.g008
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the human type I ABCA7 (full length cDNA) is localized on the
plasma membrane and mediates release of cholesterol and
phospholipids to apoA-I, while the human type II (spliced variant
cDNA) is primarily localized in the endoplasmic reticulum and
might be involved in intracellular lipid trafficking. In line with
these findings, several other studies [17,23,24] demonstrated that
ABCA7 does not function to export lipid from cells, but rather
plays an intracellular role. In the present study, we confirm that
single disruption of ABCA7 in mouse peritoneal macrophages
does not affect cholesterol efflux to apoA-I, suggesting that ABCA7
has no cholesterol efflux functionality in this cell type. We,
however, cannot exclude that the loss of function of ABCA7 is
compensated by ABCA1. As earlier mentioned, mRNA expression
and protein levels of ABCA1 were significantly induced in
peritoneal macrophages of ABCA7 KO transplanted mice,
suggestive of a compensatory up-regulation of ABCA1 in absence
of ABCA7. Disruption of ABCA1 or both ABCA1 and ABCA7
completely ablated cholesterol efflux to apoA-I, indicating that loss
of ABCA1 function could not be rescued by compensatory
mechanisms. In line with these findings, it has been previously
reported that ABCA7 does not rescue the systemic phenotype
induced by the in vivo loss of ABCA1 function in either mouse or
man [37,38,39]. Efflux of cholesterol to HDL was only
significantly reduced in peritoneal macrophages of dKO trans-
planted mice. Surprisingly, despite the observed reduction in
cholesterol efflux in vitro, in vivo peritoneal foam cell formation was
reduced upon combined deletion of ABCA1 and ABCA7. This is
probably the consequence of the observed up-regulation of
ABCG1 expression in vivo in cells lacking ABCA1 and ABCA7.
Single deletion of ABCA1 did not affect ABCG1 protein
expression. The observed up-regulation of ABCG1 in ABCA1/
ABCG1 dKO macrophages is thus most likely a direct effect of
ABCA7 deletion and not of the absence of ABCA1.
However, the reduced cholesterol efflux to HDL from
peritoneal macrophages of dKO transplanted mice in culture
seems to be in contrast to the observed compensatory upregulation
of ABCG1 expression, which can be interpreted that the increase
in ABCG1 cannot compensate for the absence of ABCA7.
Future generation of ABCA1/ABCG1/ABCA7 triple knockout
mice is expected to unequivocally establish the importance of
ABCA7 for macrophage lipid homeostasis and atherosclerotic
lesion development.
The highest expression of ABCA7 in mouse can be found in
myelo-lymphatic tissues, such as thymus, spleen, lymph node, and
bone marrow and moderate expression in lung, brain, and adrenal
glands [14,22]. No differences in weight or morphology of the
thymus, lymph nodes, and liver were observed between the four
groups. Interestingly, severe splenomegaly was observed in dKO
transplanted mice, whereas no such phenotype was present in WT,
ABCA1 KO, and ABCA7 KO transplanted mice. The spleens of
dKO transplanted mice contained white foci, which corresponded
with extreme lipid accumulation, as indicated by Oil red O
staining. Furthermore, the amount of T cells was significantly
reduced in spleens of these transplanted mice. In light of the
predominant expression of ABCA7 in macrophages and other
lympho-myeloid cell types and its anticipated role in hematopoiesis
[16], it is conceivable that ABCA7 is involved in processes
associated with immune functions. The observed reduction in T
cells in spleens of dKO transplanted mice might, thus, be a direct
result of impaired lymphopoiesis in absence of ABCA7. The
reduction in splenic T-cells, however, was only observed when
both ABCA1 and ABCA7 transporters are disrupted in hemato-
poietic cells, as single ABCA1 deficiency did not affect splenic T-
cells.
Since ABCA7 is highly expressed on erythrocytes [22] and
enhanced splenic erythropoiesis is a common cause of increased
spleen size, mRNA expression levels of genes involved in
erythropoiesis and erythroid lineage differentiation were analysed.
mRNA gene expression of different transcription factors involved
in splenic erythropoiesis, as well as the intensity of TER 119
staining were increased in LDLr KO transplanted with dKO bone
marrow. Increased erythropoiesis might be the result of disturbed
morphology of the spleen of dKO transplanted mice, due to lipid
accumulation or lymphopenia. Kam et al. [40] has previously
shown that although some erythropoiesis occurs in the spleen
under normal conditions, most splenic erythropoiesis occurs as a
response to hematologic stress. On the other hand, ABCA7 shows
potential binding sites for transcription factors with roles in
hematopoiesis [41]. Therefore, the effect on erythropoiesis
observed in spleens of dKO transplanted mice might be thus a
direct result of the hematopoietic ABCA7 deficiency.
In conclusion, single deletion of macrophage ABCA7 does not
affect cellular cholesterol efflux and atherosclerotic lesion develop-
ment in LDLr KO mice, possibly due to compensatory up-
regulation of ABCA1 expression. In addition, no synergistic role of
the transporters ABCA1 and ABCA7 in atherosclerotic lesion
development was demonstrated, despite the anticipated roles of both
transporters in macrophage lipid efflux and phagocytosis. Since
dKO transplanted mice exhibited severe splenomegaly, associated
with a decrease in CD3+ T cells and increased markers of ery-
thropoiesis, ABCA7 might have a role in hematopoiesis in spleen.
Supporting Information
Figure S1 Effect of macrophage ABCA1, ABCA7, and
combined ABCA1/ABCA7 deficiency on macrophage
staining in atherosclerotic lesions. Cryosections of the
aortic root at the level of the tricuspid valves from all groups of
mice were stained for macrophage F4/80 specific antigen.
Original magnification6400.
(EPS)
Figure S2 Effects of single macrophage, ABCA1, ABCA7
and combined macrophage ABCA1 and ABCA7 deficien-
cy on splenic macrophage, proliferation and erythroid
cells. Cryosections of spleens from all groups of mice were stained
for macrophage F4/80 specific antigen, Ki67 cell proliferation rate
marker and TER 119 erythroid lineage marker. Original
magnification6400.
(EPS)
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